User profiles for Mark R. Baker
Mark R BakerSenior Clinical Lecturer Verified email at ncl.ac.uk Cited by 5253 |
[PDF][PDF] A proposal for new diagnostic criteria for ALS
1. Background The El Escorial criteria for the diagnosis of Amyotrophic Lateral Sclerosis (ALS)
were initially published in 1994 (Brooks, 1994) and revised in 2000 (Brooks et al., 2000). …
were initially published in 1994 (Brooks, 1994) and revised in 2000 (Brooks et al., 2000). …
[HTML][HTML] Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study
Background The spectrum of neurological and psychiatric complications associated with
paediatric SARS-CoV-2 infection is poorly understood. We aimed to analyse the range and …
paediatric SARS-CoV-2 infection is poorly understood. We aimed to analyse the range and …
Long COVID: mechanisms, risk factors and recovery
R Astin, A Banerjee, MR Baker, M Dani… - Experimental …, 2023 - Wiley Online Library
New Findings What is the topic of this review? The emerging condition of long COVID, its
epidemiology, pathophysiological impacts on patients of different backgrounds, physiological …
epidemiology, pathophysiological impacts on patients of different backgrounds, physiological …
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
EMJ De Boer, VK Orie, T Williams, MR Baker… - Journal of Neurology …, 2021 - jnnp.bmj.com
Inclusions of pathogenic deposits containing TAR DNA-binding protein 43 (TDP-43) are
evident in the brain and spinal cord of patients that present across a spectrum of …
evident in the brain and spinal cord of patients that present across a spectrum of …
Contributions of descending and ascending pathways to corticomuscular coherence in humans
Non‐technical summary Neural activity in parts of the cerebral cortex related to movement
oscillates at frequencies around 20 Hz. These oscillations are correlated with similar rhythms …
oscillates at frequencies around 20 Hz. These oscillations are correlated with similar rhythms …
Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease
L Rochester, AJ Yarnall, MR Baker, RV David, S Lord… - Brain, 2012 - academic.oup.com
Gait disturbance is an early feature in Parkinson’s disease. Its pathophysiology is poorly
understood; however, cholinergic dysfunction may be a non-dopaminergic contributor to gait. …
understood; however, cholinergic dysfunction may be a non-dopaminergic contributor to gait. …
The effect of diazepam on motor cortical oscillations and corticomuscular coherence studied in man
EEG recordings from sensorimotor cortex show oscillations around 10 and 20 Hz. These
modulate with task performance, and are strongest during periods of steady contraction. The 20 …
modulate with task performance, and are strongest during periods of steady contraction. The 20 …
Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance
…, D Dick, I Imam, D Hilton, F Norwood, MR Baker… - Brain, 2014 - academic.oup.com
Despite being a canonical presenting feature of mitochondrial disease, the genetic basis of
progressive external ophthalmoplegia remains unknown in a large proportion of patients. …
progressive external ophthalmoplegia remains unknown in a large proportion of patients. …
Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease
In motor neuron disease, the focus of therapy is to prevent or slow neuronal degeneration
with neuroprotective pharmacological agents; early diagnosis and treatment are thus essential…
with neuroprotective pharmacological agents; early diagnosis and treatment are thus essential…
[HTML][HTML] Botulinum toxin: an update on pharmacology and newer products in development
Since its introduction as a treatment for strabismus, botulinum toxin (BoNT) has had a
phenomenal journey and is now recommended as first-line treatment for focal dystonia, despite …
phenomenal journey and is now recommended as first-line treatment for focal dystonia, despite …